Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,5S,8S,11S,14S,21S,24S,27S)-27,31-diamino-14-((S)-6-amino-2-((S)-6-(4-boronobenzamido)-2-((S)-2,6-diaminohexanamido)hexanamido)hexanamido)-5,11,21-tris(4-aminobutyl)-24-(4-(4-boronobenzamido)butyl)-2-(4-hydroxybenzyl)-8-isobutyl-4,7,10,13,20,23,26-heptaoxo-3,6,9,12,19,22,25-heptaazahentriacontan-1-oic acid
ID: ALA4561229
PubChem CID: 155543355
Max Phase: Preclinical
Molecular Formula: C83H140B2N20O19
Molecular Weight: 1743.78
Molecule Type: Unknown
Associated Items: